No photo of Debra Anne Goldstein

View Scopus Profile

Debra Anne Goldstein

  • 2167 Citations
19952020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Ophthalmology

Training Experience

1989Residency, McGill University School of Medicine, Canada
1993Residency, McGill University School of Medicine, Canada
1995Fellowship, University of Illinois at Chicago

Education/Academic qualification

MD, McGill University

… → 1988

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Uveitis Medicine & Life Sciences
Optical Coherence Tomography Medicine & Life Sciences
Inflammation Medicine & Life Sciences
Visual Acuity Medicine & Life Sciences
Intraocular Pressure Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Ocular Tuberculosis Medicine & Life Sciences
Anterior Uveitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2001 2020

Prot #GS-US-432-4097: A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis

Goldstein, D. A. & Koreishi, A. F.

PPD Development, Gilead Sciences, Inc.

10/24/17 → 10/24/20

Project: Research project

Prot #PSV-FAI-001: A PHASE III, MULTI-NATIONAL, MULTI-CENTER, RANDOMIZED, MASKED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A FLUOCINOLONE ACETONIDE INTRAVITREAL (FAI) INSERT IN SUBJECTS WITH CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT O

Goldstein, D. A.

PPD Development, pSivida Corp.

3/26/14 → 3/26/20

Project: Research project

Prot #CLS1001-301: PEACHTREE: A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects with Macular Edema associated with Non-Infectio

Goldstein, D. A. & Koreishi, A. F.

Chiltern International, Inc., Clearside Biomedical, Inc.

4/29/16 → 4/29/19

Project: Research project

Prot #X052132: An Open-Label, Non-Randomized, Single-Arm, Rollover Study to Continue Dosing of Gevokizumab in Subjects with Non Infectious Intermediate-, Posterior-, or Pan-Uveitis Who Each Successfully Completed Either the X052130 or the X052131 Study or

Goldstein, D. A.

XOMA (US) LLC

3/6/15 → 3/6/18

Project: Research project

Prot #X052133: A Randomized-Withdrawal, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Subjects with Behçet's Disease Uveitis

Goldstein, D. A.

XOMA (US) LLC

2/5/15 → 2/5/18

Project: Research project

Research Output 1995 2019

Moving from Syndromic Description to Etiologic Diagnosis for Uveitis

Leveque, T. K. & Goldstein, D. A., Apr 1 2019, In : JAMA ophthalmology. 137, 4, p. 438-439 2 p.

Research output: Contribution to journal › Review article

Uveitis

Partial Scleral Rupture Presenting 4 Years After Laser in Situ Keratomileusis

LaMattina, K. C., Feder, R. S., Koreishi, A. F. & Goldstein, D. A., Apr 1 2019, In : Cornea. 38, 4, p. 498-501 4 p.

Research output: Contribution to journal › Article

Laser In Situ Keratomileusis
Rupture
Astigmatism
Blister
Cornea

Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition

Sun, M. M., Levinson, R. D., Filipowicz, A., Anesi, S., Kaplan, H. J., Wang, W., Goldstein, D. A., Gangaputra, S., Swan, R. T., Sen, H. N. & Gordon, L. K., Jan 1 2019, In : Ocular Immunology and Inflammation.

Research output: Contribution to journal › Article

Uveitis
Panuveitis
Posterior Uveitis
Anterior Uveitis
Optic Neuritis
1 Citation (Scopus)

Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma

Deák, G. G., Goldstein, D. A., Zhou, M., Fawzi, A. A. & Jampol, L. M., Feb 1 2019, In : JAMA ophthalmology. 137, 2, p. E1-E5

Research output: Contribution to journal › Article

Optical Coherence Tomography
Lymphoma
Intraocular Lymphoma
Central Nervous System
Retinal Vessels
2 Citations (Scopus)

Adalimumab Treatment in Patients with Vogt–Koyanagi–Harada Disease

Couto, C., Schlaen, A., Frick, M., Khoury, M., Lopez, M., Hurtado, E. & Goldstein, D. A., Apr 3 2018, In : Ocular Immunology and Inflammation. 26, 3, p. 485-489 5 p.

Research output: Contribution to journal › Article

Immunosuppressive Agents
Inflammation
Adrenal Cortex Hormones
Therapeutics
Optic Nerve